143 related articles for article (PubMed ID: 36326317)
61. Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia.
Quick CM; Laury AR; Monte NM; Mutter GL
Am J Clin Pathol; 2012 Nov; 138(5):678-84. PubMed ID: 23086768
[TBL] [Abstract][Full Text] [Related]
62. Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.
Uccella S; Zorzato PC; Dababou S; Bosco M; Torella M; Braga A; Frigerio M; Gardella B; Cianci S; Laganà AS; Franchi MP; Garzon S
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143933
[TBL] [Abstract][Full Text] [Related]
63. Pax2 expression in simultaneously diagnosed WHO and EIN classification systems.
Joiner AK; Quick CM; Jeffus SK
Int J Gynecol Pathol; 2015 Jan; 34(1):40-6. PubMed ID: 25473752
[TBL] [Abstract][Full Text] [Related]
64. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis.
Hecht JL; Ince TA; Baak JP; Baker HE; Ogden MW; Mutter GL
Mod Pathol; 2005 Mar; 18(3):324-30. PubMed ID: 15529181
[TBL] [Abstract][Full Text] [Related]
65. Is hemoglobin A1c valuable for predicting concurrent endometrial cancer in diabetic women with endometrial intraepithelial neoplasia?
Kose C; Korpe B; Korkmaz V; Engin-Ustun Y
Gynecol Endocrinol; 2022 Nov; 38(11):1003-1007. PubMed ID: 36198328
[TBL] [Abstract][Full Text] [Related]
66. Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer.
Gonthier C; Walker F; Luton D; Yazbeck C; Madelenat P; Koskas M
Gynecol Oncol; 2014 Apr; 133(1):33-7. PubMed ID: 24680589
[TBL] [Abstract][Full Text] [Related]
67. Clinical outcome in diagnostically ambiguous foci of 'gland crowding' in the endometrium.
Huang EC; Mutter GL; Crum CP; Nucci MR
Mod Pathol; 2010 Nov; 23(11):1486-91. PubMed ID: 20676062
[TBL] [Abstract][Full Text] [Related]
68. Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma.
Jadoul P; Donnez J
Fertil Steril; 2003 Dec; 80(6):1315-24. PubMed ID: 14667859
[TBL] [Abstract][Full Text] [Related]
69. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
70. PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma.
Pavlakis K; Messini I; Vrekoussis T; Panoskaltsis T; Chrissanthakis D; Yiannou P; Stathopoulos EN
Gynecol Oncol; 2010 Dec; 119(3):516-9. PubMed ID: 20833413
[TBL] [Abstract][Full Text] [Related]
71. Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists.
Usubutun A; Mutter GL; Saglam A; Dolgun A; Ozkan EA; Ince T; Akyol A; Bulbul HD; Calay Z; Eren F; Gumurdulu D; Haberal AN; Ilvan S; Karaveli S; Koyuncuoglu M; Muezzinoglu B; Muftuoglu KH; Ozdemir N; Ozen O; Baykara S; Pestereli E; Ulukus EC; Zekioglu O
Mod Pathol; 2012 Jun; 25(6):877-84. PubMed ID: 22301705
[TBL] [Abstract][Full Text] [Related]
72. [Fertility-sparing management of endometrial cancer and atypical hyperplasia].
Gonthier C; Trefoux-Bourdet A; Luton D; Koskas M
Gynecol Obstet Fertil Senol; 2017 Feb; 45(2):112-118. PubMed ID: 28368791
[TBL] [Abstract][Full Text] [Related]
73. The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia.
Ichinose M; Fujimoto A; Osuga Y; Minaguchi T; Kawana K; Yano T; Kozuma S
Int J Gynecol Cancer; 2013 Feb; 23(2):288-93. PubMed ID: 23314282
[TBL] [Abstract][Full Text] [Related]
74. Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review.
Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Acta Obstet Gynecol Scand; 2019 Sep; 98(9):1086-1099. PubMed ID: 30793281
[TBL] [Abstract][Full Text] [Related]
75. [Preinvasive lesions in gynaecology - endometrium].
Feranec R; Mouková L; Chovanec J
Klin Onkol; 2013; 26 Suppl():S52-3. PubMed ID: 24325166
[TBL] [Abstract][Full Text] [Related]
76. Clinical Predictive Factors of Response to Treatment in Patients Undergoing Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer.
Raffone A; Travaglino A; Flacco ME; Iasevoli M; Mollo A; Guida M; Insabato L; Di Spiezio Sardo A; Carugno J; Zullo F
J Adolesc Young Adult Oncol; 2021 Apr; 10(2):193-201. PubMed ID: 32799597
[No Abstract] [Full Text] [Related]
77. The histological diagnosis of endometrial hyperplasia. Is there a need to simplify?
Dietel M
Virchows Arch; 2001 Nov; 439(5):604-8. PubMed ID: 11764378
[TBL] [Abstract][Full Text] [Related]
78. Analysis of IVF/ICSI outcomes in infertile women with early-stage endometrial cancer and atypical endometrial hyperplasia after conservative treatment.
Guo Y; Zong X; Li H; Qiao J
J Assist Reprod Genet; 2022 Jul; 39(7):1643-1651. PubMed ID: 35648323
[TBL] [Abstract][Full Text] [Related]
79. Risk factors for developing endometrial cancer after benign endometrial sampling.
Fambrini M; Sorbi F; Guaschino S
Obstet Gynecol; 2013 Feb; 121(2 Pt 1):381-382. PubMed ID: 23344297
[No Abstract] [Full Text] [Related]
80. Application of molecular classification to guiding fertility-sparing therapy for patients with endometrial cancer or endometrial intraepithelial neoplasia.
Zhang X; Chen D; Zhao X; Wang C; He Y; Chen Y; Wang J; Shen D
Pathol Res Pract; 2023 Jan; 241():154278. PubMed ID: 36580798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
